Neuroendocrine tumors Clinical Trials

Recruiting neuroendocrine tumors studies with sites across the US, sourced from ClinicalTrials.gov and refreshed daily. Free to join — find one near you below.

Clinical trials study new ways to prevent, detect, or treat neuroendocrine tumors. Joining one can give you access to investigational treatments and close monitoring by a specialist research team — at no cost — while helping advance care for others. Below are recruiting neuroendocrine tumors studies with sites across the US; use the location tools to find ones near you.

What to expect

Screening first. The study team reviews your eligibility before anything else — there's no obligation to continue.
Informed consent. You'll get a full explanation of the study, its potential risks and benefits, and can withdraw at any time.
No cost to you. Study visits, tests, and the investigational treatment are covered; many studies reimburse travel.

Recruiting neuroendocrine tumors trials

Within

Study of CTX-471 in Patients With Neural Cell Adhesion Molecule (NCAM) Positive Neuroendocrine Neoplasms

for Neuroendocrine Neoplasm

Sponsor: Compass Therapeutics

Sex: All·Age: 18+

Code: NCT07684170·Phase 2

211At-MABG in Adults With Advanced Neuroendocrine Cancers

for Pheochromocytoma

1 site in Philadelphia

Sponsor: University of Pennsylvania

Sex: All·Age: 18+

Code: NCT07661420·Phase 1

CardioNETPOL National Registry of Carcinoid Heart Disease

for Carcinoid Heart Disease

Sponsor: National Institute of Cardiology, Warsaw, Poland

Sex: All·Age: 18+

Code: NCT07450287

Study to Assess the Safety and Effectiveness of Novel Radiopharmaceutical Terbium-161 DOTATATE in Metastatic Neuroendocrine Tumors

for Neuroendocrine Neoplasms (Tumours)

Sponsor: Tata Memorial Hospital

Sex: All·Age: 18 - 70

Code: NCT07404176·Phase 2

Apply to this trial

Safety, Tolerability and Preliminary Efficacy of NEUK203-13 in Refractory Neuroendocrine Tumor Patients

for SCLC, Extensive Stage

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Sex: All·Age: 18 - 75

Code: NCT07366658·Phase 1

Apply to this trial

18F-AlF-NOTA-Octreotide PET in Neuroendocrine Neoplasms

for Neuroendocrine Tumors

Sponsor: First Affiliated Hospital of Zhejiang University

Sex: All·Age: 20 - 80

Code: NCT07102056

Study of Cabozantinib in Participants With Neuroendocrine Tumors Who Have Already Received Prior Treatment

for Neuroendocrine Tumors

Sponsor: Ipsen

Sex: All·Age: 18+

Code: NCT07314164

Apply to this trial

Sapu003 in Advanced mTOR-sensitive Solid Tumors

for Breast Cancer Metastatic

Sponsor: SAPU NANO (US) LLC

Sex: All·Age: 18+

Code: NCT07369505·Phase 1

Apply to this trial

Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.

for GEP-NET

7 sites incl. Iowa City

Sponsor: RayzeBio, Inc.

Sex: All·Age: 18+

Code: NCT07165132·Phase 1

Apply to this trial

A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors

for SST2-positive Neuroendocrine Neoplasms

22 sites incl. Phoenix

Sponsor: Crinetics Pharmaceuticals Inc.

Sex: All·Age: 18+

Code: NCT07129252·Phase 1, Phase 2

Apply to this trial

Prospective Multicenter Real-world Study of Surufatinib in Patients With Advanced Neuroendocrine Neoplasms

for Neuroendocrine Tumors

Sponsor: Shanghai Zhongshan Hospital

Sex: All·Age: 18+

Code: NCT07272512·Phase 4

Apply to this trial

Study Assessing PET Imaging With Zirconium-labelled Girentuximab in Patients With HCC, BTC or NEN

for Hepatocellular Carcinoma (HCC)

Sponsor: Nantes University Hospital

Sex: All·Age: 18+

Code: NCT06735560

Apply to this trial

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

for Metastatic Malignant Solid Neoplasm

3 sites incl. Duarte

Sponsor: Anusha Kalbasi

Sex: All·Age: 18 - 75

Code: NCT04119024·Phase 1

Apply to this trial

The Use of Guarana to Treat Fatigue in Patients With Neuroendocrine Tumors and Gynecologic Cancers (Guarana Fatigue)

for Neuroendocrine Tumors

1 site in Salt Lake City

Sponsor: University of Utah

Sex: All·Age: 18+

Code: NCT07151391·Phase 2

Apply to this trial

SVV-001 With Nivolumab and Ipilimumab in Patients With Poorly Differentiated Neuroendocrine Carcinomas (NEC) or Well-Differentiated High-Grade Neuroendocrine Tumors (NET)

for Neuroendocrine Carcinoma

1 site in Miami

Sponsor: Peter Hosein, MD

Sex: All·Age: 18+

Code: NCT06889493·Phase 1

Apply to this trial

18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis

for Lung Cancers

Sponsor: Nanjing First Hospital, Nanjing Medical University

Sex: All·Age: 18 - 75

Code: NCT06937112

Apply to this trial

61Cu-NODAGA-LM3 PET/CT for the Detection of Neuroendocrine Tumors (COPPER PET in NET)

for Neuroendocrine Tumors

Sponsor: University Hospital, Basel, Switzerland

Sex: All·Age: 18+

Code: NCT06455358·Phase 1, Phase 2

Apply to this trial

A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit

for Gastrointestinal Stromal Tumors

4 sites incl. Ann Arbor

Sponsor: Novelty Nobility, Inc.

Sex: All·Age: 18+

Code: NCT06805825·Phase 1

Apply to this trial

Phase II Study of Adebrelimab, Chemotherapy, and Apatinib for Advanced Pulmonary Neuroendocrine Tumors

for Neuroendocrine Tumors

Sponsor: Beijing Chest Hospital

Sex: All·Age: 18+

Code: NCT06764368·Phase 2

EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.

for Gastrointestinal Cancer

1 site in Cleveland

Sponsor: Case Comprehensive Cancer Center

Sex: All·Age: 18+

Code: NCT06263088

Apply to this trial

Cessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours

for Neuroendocrine Tumors

Sponsor: Australasian Gastro-Intestinal Trials Group

Sex: All·Age: 18+

Code: NCT06345079·Phase 2

Apply to this trial

Clinical-pathological Evaluation of Pit-NETs

for Pituitary

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Sex: All·Age: 18+

Code: NCT06607198

Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors

for Cancer

1 site in Detroit

Sponsor: Barbara Ann Karmanos Cancer Institute

Sex: All·Age: 18+

Code: NCT06908629

Apply to this trial

Evaluation of Study Experiences of Neuroendocrine Tumor Patients

for Neuroendocrine Tumors

1 site in San Francisco

Sponsor: Power Life Sciences Inc.

Sex: All·Age: 18+

Code: NCT05967481

Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies

for Advanced Solid Tumor

10 sites incl. Sarasota

Sponsor: Circle Pharma

Sex: All·Age: 12+

Code: NCT06577987·Phase 1

Apply to this trial

A Study of BL-M14D1 in Patients With Locally Advanced or Metastatic Small Cell Lung Cancer, Neuroendocrine Tumors and Other Solid Tumors

for Small Cell Lung Cancer

Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.

Sex: All·Age: 18 - 75

Code: NCT06505824·Phase 1

Apply to this trial

Agnostic Therapy in Rare Solid Tumors

for Urachal Cancer

Sponsor: Instituto do Cancer do Estado de São Paulo

Sex: All·Age: 18+

Code: NCT06638931·Phase 2

Apply to this trial

Irinotecan Liposomes for the Treatment of Neuroendocrine Carcinoma

for Neuroendocrine Tumors

Sponsor: First Affiliated Hospital Xi'an Jiaotong University

Sex: All·Age: 18+

Code: NCT06485739·Phase 4

Absorbed Tumor Dose in Peptide Receptor Radionuclide Therapy with Long-acting Somatostatin Analogues - ATSA Trial

for Neuroendocrine Tumors

Sponsor: The Netherlands Cancer Institute

Sex: All·Age: 18+

Code: NCT06855095·Phase 2, Phase 3

Apply to this trial

A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors

for Neuroendocrine Carcinomas

1 site in Bethesda

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18 - 120

Code: NCT06041516·Phase 1

Apply to this trial

Study of the Value of hPG80 (Circulating Progastrin) for the Diagnosis of Neuroendocrine Tumours in Patients With an MEN1 Mutation

for Neuroendocrine Tumors

Sponsor: Centre Hospitalier Universitaire Dijon

Sex: All·Age: 18 - 60

Code: NCT06430021

Apply to this trial

A Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDG

for Prostate Cancer

1 site in Sacramento

Sponsor: University of California, Davis

Sex: All·Age: 18+

Code: NCT05160480

A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy

for Neuroendocrine Tumors

4 sites incl. Atlanta

Sponsor: Chimeric Therapeutics

Sex: All·Age: 18 - 85

Code: NCT06055439·Phase 1, Phase 2

Apply to this trial

Hyperthermia Enhanced Re-irradiation of Loco-regional Recurrent Tumors

for Recurrent Cancer

Sponsor: Charite University, Berlin, Germany

Sex: All·Age: 18+

Code: NCT04889742·Phase 2

177Lu-DOTATATE Modified Delivery Based on Individualized Dosimetry

for Neuroendocrine Tumors

1 site in Iowa City

Sponsor: University of Iowa

Sex: All·Age: 18+

Code: NCT06395402·Phase 2

Apply to this trial

Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors

for Neuroendocrine Tumors

Sponsor: AC Camargo Cancer Center

Sex: All·Age: 16+

Code: NCT06472388·Phase 2

Apply to this trial

Peptide Receptor Radionuclide Therapy (PRRT) for the Treatment of Neuroendocrine Tumors

for Neuroendocrine Tumors

2 sites in Dallas

Sponsor: Methodist Health System

Sex: All·Age: 18+

Code: NCT04090034

Apply to this trial

A Real-world Study of Octreotide Microspheres in Chinese Patients With Neuroendocrine Tumors

for Neuroendocrine Tumors

Sponsor: Qilu Hospital of Shandong University

Sex: All·Age: 18+

Code: NCT06300216

Clinical Application of the J-PET Scanner Prototype

for Prostate Cancer

Sponsor: Jagiellonian University

Sex: All·Age: 18+

Code: NCT06242119

Apply to this trial

Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring

for Stage I Testicular Seminoma

Sponsor: Centre Oscar Lambret

Sex: All·Age: 18+

Code: NCT05500391·Phase 2

Apply to this trial

Influence of Tumour and Patient's Related Factors on the Response to Medical Treatments in Well Differentiated GEP-NENs

for Neuroendocrine Tumors

Sponsor: IRCCS San Raffaele

Sex: All·Age: 18+

Code: NCT06356467

Apply to this trial

Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors

for Neuroendocrine Tumors

4 sites incl. Newport Beach

Sponsor: Aadi Bioscience, Inc.

Sex: All·Age: 18+

Code: NCT05997056·Phase 2

Apply to this trial

Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus.

for Neuroendocrine Tumors

Sponsor: Grupo Espanol de Tumores Neuroendocrinos

Sex: All·Age: 18+

Code: NCT05918302·Phase 3

Apply to this trial

Development of a Predictive Model for the Risk of Metastatic Disease in PPGLs, a Retrospective Cohort Study

for Paraganglioma

Sponsor: Rigshospitalet, Denmark

Sex: All·Age: 0 - 120

Code: NCT04788927

An Open, Single-center Clinical Study of Surufatinib Combined With Temozolomide and S-1 in the First-line Treatment of Advanced Neuroendocrine Tumors

for Neuroendocrine Tumors

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Sex: All·Age: 18 - 75

Code: NCT06038461·Phase 1, Phase 2

Apply to this trial

Observational Study on GEP-and Pulm-NET Treated at FPG

for Neuroendocrine Tumors

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Sex: All·Age: 18+

Code: NCT06402695

Apply to this trial

"Receptor Radionuclide Therapy With 177Lu-DOTATOC

for Neuroendocrine Tumors

Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Sex: All·Age: 18+

Code: NCT06045260·Phase 2

Apply to this trial

Lenvatinib Plus Pembrolizumab in Well Differentiated G3 Neuroendocrine Tumors

for Neuroendocrine Tumors

1 site in San Francisco

Sponsor: University of California, San Francisco

Sex: All·Age: 18+

Code: NCT05746208·Phase 2

Apply to this trial

Comparison of Al18F-NOTA-LM3 With 68Ga-DOTATATE and 68Ga-NODAGA-LM3 PET/CT in Patients With Well-differentiated Neuroendocrine Tumors

for Neuroendocrine Tumors

Sponsor: Peking Union Medical College Hospital

Sex: All·Age: 18 - 80

Code: NCT06056362·Phase 1, Phase 2

Apply to this trial

The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study

for Cancer of Stomach

Sponsor: Western Sydney Local Health District

Sex: All·Age: 18+

Code: NCT05804331

Apply to this trial

Systemic Targeted Adaptive RadioTherapy of NeuroEndocrine Tumors.

for Neuroendocrine Tumors

Sponsor: Lund University Hospital

Sex: All·Age: 18+

Code: NCT05387603·Phase 3

Apply to this trial

Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET)

for Gastroenteropancreatico Tumors

1 site in Bethesda

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18 - 100

Code: NCT04086485·Phase 1, Phase 2

Apply to this trial

F-Tryptophan PET/CT in Human Cancers

for Intracranial Glioma

1 site in Detroit

Sponsor: Barbara Ann Karmanos Cancer Institute

Sex: All·Age: 18+

Code: NCT05556473·Phase 1

Apply to this trial

TARGETed Therapy Drug MONITOring in DIGestive Oncology

for Digestive Cancer

Sponsor: UNICANCER

Sex: All·Age: 18+

Code: NCT05443087

Apply to this trial

Improving Peptide Receptor Radionuclide Therapy With PARP Inhibitors

for Neuroendocrine Tumors

Sponsor: Erasmus Medical Center

Sex: All·Age: 18+

Code: NCT05870423·Phase 1

Apply to this trial

Lutathera and ASTX727 in Neuroendocrine Tumours

for Neuroendocrine Tumors

Sponsor: Imperial College London

Sex: All·Age: 18 - 99

Code: NCT05178693·Phase 1

Apply to this trial

Tissue Procurement and Natural History Study of Neuroendocrine Neoplasms (NENs) Including Adrenocortical Carcinoma (ACC)

for Neuroendocrine Tumors

1 site in Bethesda

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18 - 120

Code: NCT05237934

Apply to this trial

Iconographic Registry of Pancreatobiliary Endoscopy Procedures

for Pancreas Neoplasm

Sponsor: IRCCS San Raffaele

Sex: All·Age: 18+

Code: NCT06344507

Apply to this trial

Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy

for GEP-NET

13 sites incl. Irvine

Sponsor: RayzeBio, Inc.

Sex: All·Age: 18+

Code: NCT05477576·Phase 3

Apply to this trial

68Ga-HA-DOTATATE Imaging of Suspected Somatostatin Receptor Positive Tumors

for Neuroendocrine Tumors

Sponsor: University of Alberta

Sex: All·Age: All ages

Code: NCT04888481·Phase 2

Apply to this trial

Neuroendocrine tumors clinical trials — common questions

Are neuroendocrine tumors clinical trials free to join?

Yes. Participating in a neuroendocrine tumors clinical trial is free — study-related visits, tests, and the investigational treatment are provided at no cost to you. Many studies also reimburse travel and time. You never pay to take part.

Who can join a neuroendocrine tumors clinical trial?

Each neuroendocrine tumors study sets its own eligibility criteria — typically based on age, medical history, current treatments, and overall health. Every trial listed here shows its criteria, and the study team confirms your eligibility before enrollment. You can review and apply to any that look like a fit.

How do I find a neuroendocrine tumors trial near me?

Use the location controls above. We'll show recruiting neuroendocrine tumors trials with sites near you, sorted by distance. You can widen the radius or share your exact location for the closest matches.

How many neuroendocrine tumors trials are recruiting right now?

We're currently tracking roughly 31 recruiting neuroendocrine tumors trials with US sites, sourced from ClinicalTrials.gov and refreshed daily.

Looking for a specific location? Browse trials by city and state.

Neuroendocrine tumors trials by city

Detroit, MI San Francisco, CA Ann Arbor, MI Birmingham, AL Cleveland, OH Duarte, CA Gainesville, FL Irvine, CA La Jolla, CA Miami, FL Newport Beach, CA Palo Alto, CA

Related specialties

Oncology